MetaCap

Inhibrx Biosciences Statistics

NASDAQ: INBXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

68.97-5.36 (-7.21%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Inhibrx Biosciences by the numbers

Inhibrx Biosciences has a market capitalization of $1.02 billion based on 14.77M shares outstanding. With trailing EPS of $-9.06, Inhibrx Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.4% below its 50-day average and 25.4% below its 200-day average.

Average daily trading volume is 305.96K shares, or about $21.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

INBX valuation vs. peer median

INBX compared with the median of 8 peer companies
MetricINBXPeer medianDifference
Market cap$1.02B$846.91M+20%
Avg. volume305.96K954.21K-68%

Peer median across 8 companies: IMTX, VOR, TSHA, ODTX, BBTX, NVAX, PRME, MGTX.

Valuation

Price / sales (latest FY)
783.56
EPS (TTM)
$-9.06

Price and trading

Previous close
74.33
Open
72.72
Day range
68.78 – 74.45
52-week range
57.30 – 155.29
52-week change
-17.82%
Beta
—
Volume
252.13K

Dividends and events

Annual dividend
None
Next earnings date
Nov 13, 2026

Additional statistics

Market Cap
1.02B
Forward Pe
-8.20
Eps
-9.06
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
155.29
Week52 Low
57.30
Avg Volume
305.96K
Shares Outstanding
14.77M
Ma50
91.17
Ma200
92.47
Earnings Date
Nov 13, 2026
Pct From52w High
-55.59%
Pct From52w Low
20.37%

Related